aprocitentan (Pending FDA Approval)

Brand and Other Names:

Dosing & Uses

Resistant Hypertension

Pending FDA approval for resistant hypertension

Next:

Pharmacology

Mechanism of Action

Aprocitentan is an active metabolite of macitentan

Dual endothelin receptor antagonist (ERA); prevents binding of endothelin (ET)-1 to both ET-A and ET-B receptors

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.